Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Urinary Incontinence After Radical Prostatectomy Surgery is a Common Condition That Negatively Affects Daily Life. This Study Aimed to Evaluate the Efficacy and Safety of High-intensity Focused Electromagnetic Technology Used Therapeutically in Patients With Urinary Incontinence After Radical Prostatectomy. Our Study Has Shown That High-intensity Focused Electromagnetic Technology Can Safely and Effectively Treat Male Patients Suffering From Urinary Incontinence After Prostatectomy. In Addition, no Major Side Effects Were Observed in Patients After Treatment

NCT06372704 is registered in ClinicalTrials.gov with Kirsehir Ahi Evran Universitesi as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06372704 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Urinary Incontinence After Radical Prostatectomy Surgery is a Common Condition That Negatively Affects Daily Life. This Study Aimed to Evaluate the Efficacy and Safety of High-intensity Focused Electromagnetic Technology Used Therapeutically in Patients With Urinary Incontinence After Radical Prostatectomy. Our Study Has Shown That High-intensity Focused Electromagnetic Technology Can Safely and Effectively Treat Male Patients Suffering From Urinary Incontinence After Prostatectomy. In Addition, no Major Side Effects Were Observed in Patients After Treatment
Lead sponsor
Kirsehir Ahi Evran Universitesi
Phase
Observational
Overall status
Completed
Start date
February 1, 2024
Completion date
April 5, 2024
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

incontinence, pelvic floor muscle weakness, prostate cancer